Isabelle Rosa

机构：Hôpital Intercommunal de Créteil · ORCID：0000-0001-6879-3148

发表论文 141 篇 · 总被引 4049 次 · h-index 28

代表论文

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis (2025 · Journal of Hepatology · 被引 35)
Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled trial (2025 · Journal of Hepatology · 被引 19)
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort (2024 · JHEP Reports · 被引 19)
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis (2024 · Digestive and Liver Disease · 被引 6)
WED-291 Long risk of decompensation and HCC in patients with HDV- related compensated cirrhosis treated with Bulevirtide monotherapy for up to 144 weeks: the retrospective multicenter european study (Save-D) (2025 · Journal of Hepatology · 被引 4)
OS-120 Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis (2024 · Journal of Hepatology · 被引 3)